InspireMD (NSPR) Assets Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.28% |
| Sep 30, 2025 | 55.45% |
| Jun 30, 2025 | -40.10% |
| Mar 31, 2025 | -7.99% |
| Dec 31, 2024 | -1.75% |
| Sep 30, 2024 | 0.92% |
| Jun 30, 2024 | 3.77% |
| Mar 31, 2024 | 110.97% |
| Dec 31, 2023 | 93.25% |
| Sep 30, 2023 | 78.25% |
| Jun 30, 2023 | 63.70% |
| Mar 31, 2023 | -43.36% |
| Dec 31, 2022 | -37.92% |
| Sep 30, 2022 | -34.14% |
| Jun 30, 2022 | -29.35% |
| Mar 31, 2022 | -27.68% |
| Dec 31, 2021 | 123.39% |
| Sep 30, 2021 | 172.96% |
| Jun 30, 2021 | 161.41% |
| Mar 31, 2021 | 558.56% |
| Dec 31, 2020 | 79.93% |
| Sep 30, 2020 | 34.31% |
| Jun 30, 2020 | 91.08% |
| Mar 31, 2020 | -26.57% |
| Dec 31, 2019 | -19.60% |
| Sep 30, 2019 | -16.59% |
| Jun 30, 2019 | -1.97% |
| Mar 31, 2019 | 38.05% |
| Dec 31, 2018 | 101.21% |
| Sep 30, 2018 | 95.88% |
| Jun 30, 2018 | 6.33% |
| Mar 31, 2018 | -30.70% |
| Dec 31, 2017 | -35.10% |
| Sep 30, 2017 | -42.90% |
| Jun 30, 2017 | 194.93% |
| Dec 31, 2016 | 65.29% |
| Jun 30, 2016 | -77.73% |
| Dec 31, 2015 | -50.32% |
| Jun 30, 2015 | -2.84% |
| Dec 31, 2014 | -52.19% |
| Jun 30, 2014 | -32.72% |
| Mar 31, 2014 | 99.09% |
| Dec 31, 2013 | 106.66% |
| Sep 30, 2013 | 29.91% |
| Jun 30, 2013 | 29.54% |
| Mar 31, 2013 | 14.89% |
| Dec 31, 2012 | 10.82% |
| Sep 30, 2012 | 12.80% |
| Jun 30, 2012 | 41.18% |
| Dec 31, 2011 | 140.30% |